Combined therapy of dyslipidemia
Authors:
H. Rosolová
Authors‘ workplace:
II. interní klinika LF UK a FN Plzeň
; Centrum preventivní kardiologie
Published in:
Kardiol Rev Int Med 2007, 9(1): 28-30
Category:
Editorial
Overview
Adherence to long-term therapy is very low in the developed countries over the world - about 50%. Combined tablets are useful for long-term therapy, because they improve compliance to taking drugs, have less side effects and eventually potencies main therapy effects. Combined drug simvastatin + ezetimibe seem to be helpful for better control of hypercholesterolemia.
Key words:
combined therapy, adherence, cholesterol
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2007 Issue 1
Most read in this issue
- Cardiac stimulation in atrial fibrillation
- Right ventricular infarction
- Combined therapy of dyslipidemia
- Right ventricle perforation by defibrillation lead – a conservative approach? A case report.